中国基层医药
中國基層醫藥
중국기층의약
CHINESE JOURNAL OF PRIMARY MEDICINE AND PHARMACY
2011年
2期
175-176
,共2页
肝炎%血糖%甲胎蛋白%胆碱脂酶
肝炎%血糖%甲胎蛋白%膽堿脂酶
간염%혈당%갑태단백%담감지매
Hepatitis%Glucose%Alpha-fetoprotein%Cholinesterase
目的 探讨血糖、甲胎蛋白和胆碱脂酶水平对重型肝炎的诊断以及预后判断价值.方法 回顾性分析慢性乙型肝炎、肝硬化失代偿、慢性重型肝炎、亚急性重型肝炎患者之间,以及重型肝炎好转组与死亡组之间血糖、甲胎蛋白、胆碱脂酶的差异.结果 亚急性重型肝炎、慢性重型肝炎患者血糖和胆碱脂酶水平明显低于慢性乙型肝炎及肝硬化患者(均P<0.05);而甲胎蛋白水平显著高于慢性乙型肝炎(P<0.01);重型肝炎好转组血糖、甲胎蛋白、胆碱脂酶水平明显高于死亡组(均P<0.05).结论 血糖、甲胎蛋白、胆碱脂酶检测对肝脏疾病的进展程度及预后估计有重要判断价值.
目的 探討血糖、甲胎蛋白和膽堿脂酶水平對重型肝炎的診斷以及預後判斷價值.方法 迴顧性分析慢性乙型肝炎、肝硬化失代償、慢性重型肝炎、亞急性重型肝炎患者之間,以及重型肝炎好轉組與死亡組之間血糖、甲胎蛋白、膽堿脂酶的差異.結果 亞急性重型肝炎、慢性重型肝炎患者血糖和膽堿脂酶水平明顯低于慢性乙型肝炎及肝硬化患者(均P<0.05);而甲胎蛋白水平顯著高于慢性乙型肝炎(P<0.01);重型肝炎好轉組血糖、甲胎蛋白、膽堿脂酶水平明顯高于死亡組(均P<0.05).結論 血糖、甲胎蛋白、膽堿脂酶檢測對肝髒疾病的進展程度及預後估計有重要判斷價值.
목적 탐토혈당、갑태단백화담감지매수평대중형간염적진단이급예후판단개치.방법 회고성분석만성을형간염、간경화실대상、만성중형간염、아급성중형간염환자지간,이급중형간염호전조여사망조지간혈당、갑태단백、담감지매적차이.결과 아급성중형간염、만성중형간염환자혈당화담감지매수평명현저우만성을형간염급간경화환자(균P<0.05);이갑태단백수평현저고우만성을형간염(P<0.01);중형간염호전조혈당、갑태단백、담감지매수평명현고우사망조(균P<0.05).결론 혈당、갑태단백、담감지매검측대간장질병적진전정도급예후고계유중요판단개치.
Objective To study clinical value of blood glucose, AFP and cholinesterase levels on the diagnosis and prognosis of severe hepatitis. Methods Retrospective analysis of chronic hepatitis B, cirrhosis, chronic severe hepatitis, subacute severe hepatitis was carried out. In severe hepatitis patients, between the improved group and death group, blood glucose, AFP, cholinesterase differences, evaluate blood glucose, alpha-fetoprotein, cholinesterase levels on the diagnosis and prognosis of severe hepatitis value were compared. Results Subacute severe hepatitis, chronic severe hepatitis patients and blood cholinesterase levels were significantly lower than that in patients with chronic hepatitis B and liver cirrhosis(all P < 0.05) ;and alpha-fetoprotein level was significantly higher than the level of chronic hepatitis B patients(P < 0. 01) ;improved levels of blood glucose in patients with severe hepatitis, AFP, cholinesterase levels were significantly higher than the level of death group (all P < 0.05). Conclusion Blood glucose, AFP, cholinesterase levels of liver disease progression and prognosis were important to determine the value.